Robert Pilson
Eisai (United States)(US)
Publications by Year
Research Areas
Cytomegalovirus and herpesvirus research, Monoclonal and Polyclonal Antibodies Research, Macrophage Migration Inhibitory Factor, HIV Research and Treatment, Diabetes Treatment and Management
Most-Cited Works
- → Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys(1991)104 cited
- → Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor(1993)79 cited
- → Humanized antibodies against the α-chain of the IL-2 receptor and against the β-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases(1997)70 cited
- → Coadministration of lorcaserin and phentermine for weight management: A 12‐week, randomized, pilot safety study(2017)41 cited
- → Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab(2011)24 cited
- → Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation(1997)9 cited
- → Dialyzable lymphoid extract (DLE) from mice resistant to STZ-induced diabetogenesis can interrupt the progress of diabetes in STZ-treated CD-1 mice(1996)1 cited
- → ISOLATION AND PURIFICATION OF ANTIGEN-SPECIFIC INDUCER AND SUPPRESSOR FACTORS FROM POOLED LEUKOCYTE DIALYSATES OF UNSELECTED DONORS BY AFFINITY ADSORPTION(1983)1 cited
- → HUMAN T-CELL HYBRIDOMA FORMATION FOR POTENTIAL PRODUCTION OF TRANSFER FACTOR(1984)
- → CONTRIBUTORS(1983)